Association between density of coronary artery calcification and serum magnesium levels among patients with chronic kidney disease

PLoS ONE

Volumn 11, Issue 9, 2016, Pages

  Sakaguchi, Yusuke ^a   Hamano, Takayuki ^a   Nakano, Chikako ^b   Obi, Yoshitsugu ^a   Matsui, Isao ^a   Kusunoki, Yasuo ^a   Mori, Daisuke ^a   Oka, Tatsufumi ^a   Hashimoto, Nobuhiro ^a   Takabatake, Yoshitsugu ^a   Takahashi, Atsushi ^a   Kaimori, Jun Ya ^a   Moriyama, Toshiki ^c   Yamamoto, Ryohei ^c   Horio, Masaru ^a   Sugimoto, Ken ^a   Yamamoto, Koichi ^a   Rakugi, Hiromi ^a   Isaka, Yoshitaka ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Kisei Hospital   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 23; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MAGNESIUM ION; PHOSPHATE;

AGATSTON SCORE; AGED; ARTICLE; ATHEROSCLEROSIS; BONE DISEASE; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY CALCIFICATION; DIABETES MELLITUS; DISEASE ASSOCIATION; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; HEMODIALYSIS; HUMAN; INFLAMMATION; LIMIT OF QUANTITATION; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; PATHOPHYSIOLOGY; PHOSPHATE BLOOD LEVEL; RETROSPECTIVE STUDY; SMOKING;

EID: 84991696863     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0163673     Document Type: Article

References (44)

1. Yeboah J, McClelland RL, Polonsky TS, Burke GL, Sibley CT, O'Leary D, et al. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA 2012;308:788-795. doi: 10.1001/jama.2012.9624 PMID: 22910756
2. Kavousi M, Elias-Smale S, Rutten JH, Leening MJ, Vliegenthart R, Verwoert GC, et al. Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study. Ann Intern Med 2012;156:438-444. doi: 10.7326/0003-4819-156-6-201203200-00006 PMID: 22431676
3. Russo D, Corrao S, Battaglia Y, Andreucci M, Caiazza A, Carlomagno A, et al. Progression of coronary artery calcification and cardiac events in patients with chronic renal disease not receiving dialysis. Kidney Int 2011;80:112-118. doi: 10.1038/ki.2011.69 PMID: 21451461
4. Watanabe R, Lemos MM, Manfredi SR, Draibe SA, Canziani ME. Impact of cardiovascular calcification in nondialyzed patients after 24 months of follow-up. Clin J Am Soc Nephrol 2010;5:189-194. doi: 10. 2215/CJN.06240909 PMID: 19965535
5. Matsushita K, Sang Y, Ballew SH, Shlipak M, Katz R, Rosas SE, et al. Subclinical atherosclerosis measures for cardiovascular prediction in CKD. J Am Soc Nephrol 2015;26:439-447 doi: 10.1681/ASN. 2014020173 PMID: 25145930
6. Matsuoka M, Iseki K, Tamashiro M, Fujimoto N, Higa N, Touma T, et al. Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis. Clin Exp Nephrol 2004;8:54-58. PMID: 15067517
7. Block GA, Raggi P, Bellasi A, Kooienga L, Spiegel DM. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int 2007;71:438-441 PMID: 17200680
8. Shantouf RS, Budoff MJ, Ahmadi N, Ghaffari A, Flores F, Gopal A, et al. Total and individual coronary artery calcium scores as independent predictors of mortality in hemodialysis patients. Am J Nephrol 2010;31:419-425 doi: 10.1159/000294405 PMID: 20389057
9. Coen G, Pierantozzi A, Spizzichino D, Sardella D, Mantella D, Manni M, et al. Risk factors of one year increment of coronary calcifications and survival in hemodialysis patients. BMC Nephrol 2010;11:10 doi: 10.1186/1471-2369-11-10 PMID: 20565936
10. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990;15:827-832 PMID: 2407762
11. Criqui MH, Denenberg JO, Ix JH, McClelland RL, Wassel CL, Rifkin DE, et al. Calcium density of coronary artery plaque and risk of incident cardiovascular events. JAMA 2014;311:271-278. doi: 10. 1001/jama.2013.282535 PMID: 24247483
12. Huang YL, Lin HS, Wu CC, Wu FZ, Yeh C, Chiou KR, et al. CT attenuation features of individual calcified coronary plaque: differences among asymptomatic, stable angina pectoris, and acute coronary syndrome groups. PLoS One 2015;10:e0131254. doi: 10.1371/journal.pone.0131254 PMID: 26106881
13. Ehara S, Kobayashi Y, Yoshiyama M, Shimada K, Shimada Y, Fukuda D, et al. Spotty calcification typifies the culprit plaque in patients with acute myocardial infarction: an intravascular ultrasound study. Circulation 2004;110:3424-3429 PMID: 15557374
14. Schwarz U, Buzello M, Ritz E, Stein G, Raabe G, Wiest G, etal. Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol Dial Transplant 2000;15:218-223 PMID: 10648668
15. Nakamura S, Ishibashi-Ueda H, Niizuma S, Yoshihara F, Horio T, Kawano Y. Coronary calcification in patients with chronic kidney disease and coronary artery disease. Clin J Am Soc Nephrol 2000;4:1892-1900
16. Gross ML, Meyer HP, Ziebart H, Rieger P, Wenzel U, Amann K, et al. Calcification of coronary intima and media: immunohistochemistry, backscatter imaging, and x-ray analysis in renal and nonrenal patients. Clin J Am Soc Nephrol 2007;2:121-134 PMID: 17699396
17. Kono K, Fujii H, Nakai K, Goto S, Shite J, Hirata K, et al. Composition and plaque patterns of coronary culprit lesions and clinical characteristics of patients with chronic kidney disease. Kidney Int 2012;82:344-351 doi: 10.1038/ki.2012.118 PMID: 22513825
18. Shanahan CM, Crouthamel MH, Kapustin A, Giachelli CM. Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circ Res 2011;109:697-711 doi: 10.1161/CIRCRESAHA.110.234914 PMID: 21885837
19. Montezano AC, Zimmerman D, Yusuf H, Burger D, Chignalia AZ, Wadhera V, et al. Vascular smooth muscle cell differentiation to an osteogenic phenotype involves TRPM7 modulation by magnesium. Hypertension 2010;56:453-462 doi: 10.1161/HYPERTENSIONAHA.110.152058 PMID: 20696983
20. Kircelli F, Peter ME, Sevinc Ok E, Celenk FG, Yilmaz M, Steppan S, et al. Magnesium reduces calcification in bovine vascular smooth muscle cells in a dose-dependent manner. Nephrol Dial Transplant 2012;27:514-521. doi: 10.1093/ndt/gfr321 PMID: 21750166
21. Salem S, Bruck H, Bahlmann FH, Peter M, Passlick-Deetjen J, Kretschmer A, et al. Relationship between magnesium and clinical biomarkerson inhibition of vascular calcification. Am J Nephrol 2012;35:31-39. doi: 10.1159/000334742 PMID: 22179063
22. Louvet L, Buchel J, Steppan S, Passlick-Deetjen J, Massy ZA. Magnesium prevents phosphateinduced calcification in human aortic vascular smooth muscle cells. Nephrol Dial Transplant 2013;28:869-878 doi: 10.1093/ndt/gfs520 PMID: 23229924
23. Montes de Oca A, Guerrero F, Martinez-Moreno JM, Madueño JA, Herencia C, Peralta A, et al. Magnesium inhibits Wnt/(3-catenin activity and reverses the osteogenic transformation of vascular smooth muscle cells. PLoS One 2014;9:e89525 doi: 10.1371/journal.pone.0089525 PMID: 24586847
24. Louvet L, Bazin D, Buchel J, Steppan S, Passlick-Deetjen J, Massy ZA. Characterisation of calcium phosphate crystals on calcified human aortic vascular smooth muscle cells and potential role of magnesium. PLoS One 2015;10:e0115342. doi: 10.1371/journal.pone.0115342 PMID: 25607936
25. Xu J, Bai Y, Jin J, Zhang J, Zhang S, Cui L, et al. Magnesium modulates the expression levels of calcification-associated factors to inhibit calcification in a time-dependent manner. Exp Ther Med 2015;9:1028-1034 PMID: 25667672
26. Bai Y, Zhang J, Xu J, Cui L, Zhang H, Zhang S, et al. Magnesium prevents (3-glycerophosphateinduced calcification in rat aortic vascular smooth muscle cells. Biomed Rep 2015;3:593-597. PMID: 26171172
27. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009;53:982-992 doi: 10.1053/j.ajkd.2008.12.034 PMID: 19339088
28. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney inter., Suppl. 2013;3:1-150.
29. Caliskan Y, Demirturk M, Ozkok A, et al. Coronary artery calcification and coronary flow velocity in haemodialysis patients. Nephrol Dial Transplant 25:2685-2690, 2010. doi: 10.1093/ndt/gfq113 PMID: 20190240
30. Bellasi A, Ferramosca E, Ratti C, Block G, Raggi P. The density of calcified plaques and the volume of calcium predict mortality in hemodialysis patients. Atherosclerosis. 2016. pii: S0021-9150 (16) 30109-5.
31. Massy ZA, Drueke TB. Magnesium and cardiovascular complications of chronic kidney disease. Nat Rev Nephrol 2015;11:432-442 doi: 10.1038/nrneph.2015.74 PMID: 25963594
32. Alhosaini M, Leehey DJ. Magnesium and Dialysis: The Neglected Cation. Am J Kidney Dis 2015;66:523-531 doi: 10.1053/j.ajkd.2015.01.029 PMID: 25864370
33. Van Laecke S, Van Biesen W, Vanholder R. Hypomagnesaemia, the kidney and the vessels. Nephrol Dial Transplant 2012;27:4003-4010 doi: 10.1093/ndt/gfs126 PMID: 22610987
34. Sakaguchi Y, Fujii N, Shoji T, Hayashi T, Rakugi H, Isaka Y. Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis. Kidney Int 2014;85:174-181 doi: 10.1038/ki.2013.327 PMID: 23986148
35. Sakaguchi Y, Fujii N, Shoji T, Hayashi T, Rakugi H, Iseki K, et al. Magnesium modifies the cardiovascular mortality risk associated with hyperphosphatemia in patients undergoing hemodialysis: a cohort study. PLoS One 2014;9:e116273 doi: 10.1371/journal.pone.0116273 PMID: 25545498
36. Kanbay M, Yilmaz MI, Apetrii M, Saglam M, Yaman H, Unal HU, et al. Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients. Am J Nephrol 2012;36:228-237 PMID: 22948239
37. Meema HE, Oreopoulos DG, Rapoport A. Serum magnesium level and arterial calcification in endstage renal disease. Kidney Int 1987;32:388-394 PMID: 3669498
38. Ishimura E, Okuno S, Kitatani K, Tsuchida T, Yamakawa T, Shioi A, et al. Significant association between the presence of peripheral vascular calcification and lower serum magnesium in hemodialysis patients. Clin Nephrol 2007;68:222-227 PMID: 17969489
39. Cheng PT, Grabher JJ, LeGeros RZ. Effects of magnesium on calcium phosphate formation. Magnesium 1988;7:123-132 PMID: 2846970
40. Schlieper G, Aretz A, Verberckmoes SC, Kruger T, Behets GJ, Ghadimi R, et al. Ultrastructural analysis of vascular calcifications in uremia. J Am Soc Nephrol 2010;21:689-696 doi: 10.1681/ASN. 2009080829 PMID: 20203159
41. Kovacic JC, Moreno P, Nabel EG, Hachinski V, Fuster V. Cellular senescence, vascular disease, and aging: part 2 of a 2-part review: clinical vascular disease in the elderly. Circulation 2011;123:1900-1910 doi: 10.1161/CIRCULATIONAHA.110.009118 PMID: 21537006
42. Russo D, Palmiero G, De Blasio AP, Balletta MM, Andreucci VE. Coronary artery calcification in patients with CRF not undergoing dialysis. Am J Kidney Dis 2004;44:1024-1030 PMID: 15558523
43. Khan AM, Chirinos JA, Litt H, Yang W, Rosas SE. FGF-23 and the progression of coronary arterial calcification in patients new to dialysis. Clin J Am Soc Nephrol 2012;7:2017-2022. doi: 10.2215/CJN. 02160212 PMID: 22997345
44. Arnaud MJ. Update on the assessment of magnesium status. Br J Nutr. 2008;99 Suppl 3:S24-36. doi: 10.1017/S000711450800682X PMID: 18598586